Portola Pharmaceuticals Inc. buy melinda
Start price
01.11.17
/
50%
€49.45
Target price
01.05.18
€55.50
Performance (%)
-28.29%
End price
01.05.18
€35.46
Summary
This prediction ended on 01.05.18 with a price of €35.46. The price of Portola Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.29%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
iShares Core DAX® | 1.080% | -2.933% | 12.885% | 14.247% |
iShares Nasdaq 100 | 0.362% | 7.015% | 36.826% | 57.151% |
iShares Nikkei 225® | -1.155% | -1.155% | 5.073% | 3.799% |
iShares S&P 500 | 0.806% | 4.388% | 30.269% | 49.772% |
Comments by melinda for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
Inhibitoren der internationalen Markt Inhibitoren der Janus - Kinase und die Möglichkeit einer klinischen Studie Insight 2023
(Laufzeit überschritten)
Stopped prediction by melinda for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.89
31.03.19
31.03.19
€36.08
06.07.20
06.07.20
-49.81%
06.07.20
06.07.20
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.60
01.11.17
01.11.17
€50.06
01.05.18
01.05.18
-28.29%
01.05.18
01.05.18
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€52.50
26.06.17
26.06.17
€63.14
18.07.17
18.07.17
10.70%
18.07.17
18.07.17
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.13
30.03.16
30.03.16
€27.06
07.06.16
07.06.16
35.27%
07.06.16
07.06.16